AK Medical Holdings Ltd.(HK:1789)
HK$4.70-0.07 (-1.47%)
HK:1789
AK Medical Holdings Ltd. financials statements
HK$4.70
At close:-0.07 (-1.47%)
Want to see HK:1789 full AI Analyst Report?
AK Medical Holdings Ltd. (1789) Ratios
1 Followers
AK Medical Holdings Ltd. Ratios
HK:1789's free cash flow for Q2 2026 was ¥131.24M. For the 2026 fiscal year, HK:1789's free cash flow was decreased by ¥-49.23M and operating cash flow was ¥180.47M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.10 | 3.65 | 3.96 | 4.73 | 3.95 |
| Quick Ratio | 3.41 | 2.83 | 2.77 | 3.81 | 3.09 |
| Cash Ratio | 0.57 | 0.59 | 0.66 | 1.43 | 0.97 |
| Solvency Ratio | 0.59 | 0.49 | 0.45 | 0.54 | 0.29 |
| Operating Cash Flow Ratio | 0.64 | 0.76 | 0.07 | 0.56 | 0.36 |
| Short-Term Operating Cash Flow Coverage | 5.82 | 7.46 | 1.59 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 1.95B | ¥ 1.48B | ¥ 1.36B | ¥ 1.53B | ¥ 1.36B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.03 | 0.03 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.05 | 0.04 | 0.04 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.26 | 1.26 | 1.24 | 1.28 |
| Debt Service Coverage Ratio | 5.67 | 5.31 | 12.10 | 132.17 | 104.65 |
| Interest Coverage Ratio | 127.13 | 325.87 | 164.32 | 101.19 | 61.80 |
| Debt to Market Cap | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.13 | 0.09 | 0.08 | 0.04 | 0.04 |
| Net Debt to EBITDA | -0.48 | -0.68 | -0.76 | -1.82 | -2.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 60.54% | 60.03% | 61.66% | 60.49% | 65.56% |
| EBIT Margin | 25.22% | 22.34% | 21.25% | 23.05% | 14.47% |
| EBITDA Margin | 32.43% | 27.60% | 29.56% | 30.69% | 24.21% |
| Operating Profit Margin | 25.22% | 22.34% | 19.33% | 20.91% | 13.06% |
| Pretax Profit Margin | 26.64% | 23.75% | 21.13% | 22.84% | 14.26% |
| Net Profit Margin | 22.87% | 20.35% | 16.65% | 19.46% | 12.16% |
| Continuous Operations Profit Margin | 22.87% | 20.35% | 16.65% | 19.46% | 12.16% |
| Net Income Per EBT | 85.85% | 85.65% | 78.79% | 85.22% | 85.32% |
| EBT Per EBIT | 105.64% | 106.33% | 109.28% | 109.23% | 109.17% |
| Return on Assets (ROA) | 9.25% | 8.21% | 6.06% | 7.38% | 3.56% |
| Return on Equity (ROE) | 11.64% | 10.38% | 7.61% | 9.13% | 4.56% |
| Return on Capital Employed (ROCE) | 12.44% | 10.98% | 8.44% | 9.41% | 4.70% |
| Return on Invested Capital (ROIC) | 10.41% | 9.16% | 6.56% | 7.97% | 3.99% |
| Return on Tangible Assets | 9.77% | 8.73% | 6.50% | 8.17% | 3.90% |
| Earnings Yield | 5.92% | 5.39% | 2.84% | 2.14% | 1.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.13 | 2.33 | 1.99 | 1.93 | 1.44 |
| Payables Turnover | 4.21 | 3.54 | 2.40 | 2.68 | 2.83 |
| Inventory Turnover | 1.27 | 1.10 | 0.70 | 1.03 | 0.62 |
| Fixed Asset Turnover | 2.12 | 1.97 | 2.15 | 2.87 | 2.10 |
| Asset Turnover | 0.40 | 0.40 | 0.36 | 0.38 | 0.29 |
| Working Capital Turnover Ratio | 0.82 | 0.88 | 0.70 | 0.68 | 0.52 |
| Cash Conversion Cycle | 370.97 | 384.60 | 549.59 | 406.27 | 713.98 |
| Days of Sales Outstanding | 170.99 | 156.34 | 183.54 | 189.21 | 254.27 |
| Days of Inventory Outstanding | 286.62 | 331.42 | 518.30 | 353.34 | 588.82 |
| Days of Payables Outstanding | 86.64 | 103.16 | 152.24 | 136.27 | 129.12 |
| Operating Cycle | 457.61 | 487.75 | 701.84 | 542.54 | 843.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.37 | 0.40 | 0.03 | 0.22 | 0.16 |
| Free Cash Flow Per Share | 0.28 | 0.26 | -0.14 | 0.11 | 0.09 |
| Dividend Paid and CapEx Coverage Ratio | 2.40 | 2.17 | 0.13 | 1.67 | 1.56 |
| Capital Expenditure Coverage Ratio | 4.07 | 2.78 | 0.17 | 2.00 | 2.32 |
| Operating Cash Flow Coverage Ratio | 2.89 | 4.54 | 0.40 | 6.26 | 4.25 |
| Operating Cash Flow to Sales Ratio | 0.28 | 0.34 | 0.03 | 0.23 | 0.23 |
| Free Cash Flow Yield | 5.52% | 5.69% | -2.53% | 1.26% | 1.68% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17.07 | 18.56 | 35.22 | 46.83 | 64.58 |
| Price-to-Sales (P/S) Ratio | 3.87 | 3.78 | 5.86 | 9.11 | 7.86 |
| Price-to-Book (P/B) Ratio | 1.97 | 1.93 | 2.68 | 4.27 | 2.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 18.13 | 17.58 | -39.56 | 79.11 | 59.58 |
| Price-to-Operating Cash Flow Ratio | 13.67 | 11.27 | 189.03 | 39.47 | 33.87 |
| Price-to-Earnings Growth (PEG) Ratio | 0.85 | 0.33 | -3.17 | 0.40 | -0.92 |
| Enterprise Value Multiple | 11.44 | 13.00 | 19.07 | 27.88 | 30.10 |
| Enterprise Value | 5.50B | 4.83B | 6.17B | 9.00B | 5.55B |
| EV to EBITDA | 11.44 | 13.00 | 19.07 | 27.88 | 30.10 |
| EV to Sales | 3.71 | 3.59 | 5.64 | 8.56 | 7.29 |
| EV to Free Cash Flow | 17.40 | 16.71 | -38.04 | 74.27 | 55.26 |
| EV to Operating Cash Flow | 13.12 | 10.71 | 181.75 | 37.06 | 31.41 |
| Tangible Book Value Per Share | 2.43 | 2.19 | 1.92 | 1.78 | 1.62 |
| Shareholders’ Equity Per Share | 2.60 | 2.36 | 2.10 | 2.02 | 1.83 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.14 | 0.21 | 0.15 | 0.15 |
| Revenue Per Share | 1.32 | 1.21 | 0.96 | 0.95 | 0.68 |
| Net Income Per Share | 0.30 | 0.25 | 0.16 | 0.18 | 0.08 |
| Tax Burden | 0.86 | 0.86 | 0.79 | 0.85 | 0.85 |
| Interest Burden | 1.06 | 1.06 | 0.99 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.10 | 0.10 | 0.13 | 0.11 | 0.15 |
| SG&A to Revenue | 0.28 | 0.29 | 0.12 | 0.11 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Income Quality | 1.27 | 1.41 | 0.15 | 1.01 | 1.63 |
Currency in CNY
